Cooperativa.cl on MSN
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced interim ...
Data Descriptors, Scientific Data's primary article type, describe datasets. These must be made available to editors and referees at the time of submission and be shared with the scientific community ...
A new University of Oxford-led study, published in The Lancet Planetary Health, is the first to link daily temperature data ...
Around one-third of Delhi’s annual PM2.5 pollution is made up of secondary ammonium sulfate, with its share rising sharply during the city’s worst po ...
To date, Leegality has raised a total of $6.63 million across three rounds. Following the rollout of the Digital Personal ...
As U.S. border inspections intensify, privacy experts explain when using a burner phone may help limit what agents can ...
NASA-based analysis shows ammonium sulphate forms nearly one-third of annual PM2.5, driven by chemical reactions rather than direct local emissions.
Among survivors of non-small cell lung cancer, nearly 8% developed non-lung secondary cancers over about 6 years, and this ...
"A stagnant yield curve is resulting from supply having wound down and munis drawing steadiness from a likewise calm UST market," said Kim Olsan, senior fixed income portfolio manager.
Dominion Energy, Inc. is rated a Buy due to its resilient demand and pricing power into 2026. Learn more about D stock here.
Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results